Disc Medicine (IRON) News Today $52.47 -0.02 (-0.04%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$52.42 -0.05 (-0.09%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Disc Medicine, Inc. (NASDAQ:IRON) Director Sells $310,483.18 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 5,738 shares of the firm's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $54.11, for a total transaction of $310,483.18. Following the completion of the transaction, the director now owns 186,541 shares of the company's stock, valued at approximately $10,093,733.51. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.March 27 at 7:46 PM | marketbeat.comIs Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode?March 27 at 11:52 AM | msn.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 5,738 Shares of StockMarch 27 at 6:03 AM | insidertrades.comRaymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON)Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 88,002 shares of the company's stock, valuedMarch 25 at 3:19 AM | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $2,142,217.12 in StockMarch 24, 2025 | americanbankingnews.comWith 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backingMarch 23, 2025 | uk.finance.yahoo.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $540,594.00 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 10,011 shares of the company's stock in a transaction on Friday, March 21st. The shares were sold at an average price of $54.00, for a total transaction of $540,594.00. Following the completion of the transaction, the director now owns 187,297 shares of the company's stock, valued at approximately $10,114,038. The trade was a 5.07 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.March 22, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 39,656 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 39,656 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $54.02, for a total value of $2,142,217.12. Following the completion of the sale, the director now owns 188,981 shares of the company's stock, valued at approximately $10,208,753.62. This trade represents a 17.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.March 22, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 10,011 Shares of StockMarch 22, 2025 | insidertrades.comVictoria’s Secret, Bitdeer, and More Stocks See Activist ActionMarch 21, 2025 | msn.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of "Buy" by AnalystsMarch 20, 2025 | americanbankingnews.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by AnalystsDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has earned an average rating of "Buy" from the eleven analysts that are covering the company, MarketBeat.com reports. Ten analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. TMarch 20, 2025 | marketbeat.comCantor Fitzgerald Raises Disc Medicine (NASDAQ:IRON) Price Target to $132.00Cantor Fitzgerald upped their target price on shares of Disc Medicine from $99.00 to $132.00 and gave the company an "overweight" rating in a report on Tuesday.March 19, 2025 | marketbeat.comCantor Fitzgerald Boosts Disc Medicine (NASDAQ:IRON) Price Target to $132.00March 19, 2025 | americanbankingnews.comDisc Medicine (IRON) Gets a Buy from Cantor FitzgeraldMarch 19, 2025 | markets.businessinsider.comDisc Medicine price target raised to $132 from $99 at Cantor FitzgeraldMarch 18, 2025 | msn.comDisc Medicine (NASDAQ:IRON) Shares Down 3% - Here's What HappenedDisc Medicine (NASDAQ:IRON) Trading Down 3% - Time to Sell?March 15, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Mona Ashiya Sells 83,182 SharesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 83,182 shares of the company's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $54.45, for a total transaction of $4,529,259.90. Following the sale, the director now directly owns 194,209 shares in the company, valued at $10,574,680.05. This represents a 29.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.March 13, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 202,146 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 202,146 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $54.29, for a total transaction of $10,974,506.34. Following the completion of the transaction, the director now directly owns 208,742 shares of the company's stock, valued at $11,332,603.18. This represents a 49.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.March 13, 2025 | marketbeat.comMona Ashiya Sells 83,182 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockMarch 13, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Victory Capital Management Inc.Victory Capital Management Inc. raised its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 236,244 shares of the company's stock after acquiring an additionMarch 13, 2025 | marketbeat.comDisc Medicine (IRON) to Release Quarterly Earnings on ThursdayDisc Medicine (NASDAQ:IRON) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comMorgan Stanley Reaffirms Overweight Rating for Disc Medicine (NASDAQ:IRON)Morgan Stanley reissued an "overweight" rating and set a $85.00 price target on shares of Disc Medicine in a report on Friday.March 8, 2025 | marketbeat.comCantor Fitzgerald Comments on Disc Medicine FY2025 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for Disc Medicine in a research note issued to investors on Wednesday, March 5th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings per share ofMarch 8, 2025 | marketbeat.comDisc Medicine assumed with an Overweight at Morgan StanleyMarch 8, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)March 7, 2025 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Disc Medicine (IRON)March 4, 2025 | markets.businessinsider.comDisc Medicine price target raised to $75 from $73 at ScotiabankMarch 3, 2025 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at ScotiabankScotiabank increased their target price on shares of Disc Medicine from $73.00 to $75.00 and gave the stock a "sector outperform" rating in a report on Monday.March 3, 2025 | marketbeat.comHC Wainwright Predicts Disc Medicine FY2029 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Disc Medicine in a report issued on Friday, February 28th. HC Wainwright analyst D. Tsao anticipates that the company will post earnings of $6.36 per share for the year. HCMarch 3, 2025 | marketbeat.comLeerink Partnrs Comments on Disc Medicine Q1 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Disc Medicine in a research report issued on Thursday, February 27th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($1.01) per sMarch 3, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPSDisc Medicine (NASDAQ:IRON - Get Free Report) posted its earnings results on Thursday. The company reported ($0.98) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.08.February 28, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Now Covered by Analysts at TD CowenTD Cowen began coverage on shares of Disc Medicine in a report on Thursday. They issued a "buy" rating for the company.February 28, 2025 | marketbeat.comDisc Medicine Inc: Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateFebruary 28, 2025 | finanznachrichten.deDisc Medicine initiated with a Buy at TD CowenFebruary 28, 2025 | markets.businessinsider.comDisc Medicine, Inc. Reports Financial Results and Key Clinical Developments, Targeting NDA Submission for Bitopertin in EPP by H2 2025February 27, 2025 | quiverquant.comDisc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateFebruary 27, 2025 | globenewswire.comDisc Medicine to Participate in Upcoming Investor ConferencesFebruary 26, 2025 | globenewswire.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of "Buy" from BrokeragesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been given a consensus recommendation of "Buy" by the ten research firms that are currently covering the firm, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation and one has issued a strong buy reFebruary 23, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) COO Sells 1,610 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) COO Jonathan Yen-Wen Yu sold 1,610 shares of the business's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $54.58, for a total transaction of $87,873.80. Following the sale, the chief operating officer now directly owns 40,555 shares in the company, valued at approximately $2,213,491.90. This represents a 3.82 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.February 21, 2025 | marketbeat.comJean M. Franchi Sells 3,136 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CFO Jean M. Franchi sold 3,136 shares of Disc Medicine stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $54.58, for a total transaction of $171,162.88. Following the completion of the sale, the chief financial officer now owns 69,530 shares of the company's stock, valued at $3,794,947.40. This trade represents a 4.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.February 21, 2025 | marketbeat.comPamela Stephenson Sells 3,137 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider Pamela Stephenson sold 3,137 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $54.58, for a total value of $171,217.46. Following the completion of the sale, the insider now owns 69,529 shares in the company, valued at approximately $3,794,892.82. The trade was a 4.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.February 21, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) CEO John D. Quisel Sells 5,574 SharesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CEO John D. Quisel sold 5,574 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $54.58, for a total transaction of $304,228.92. Following the transaction, the chief executive officer now directly owns 154,828 shares in the company, valued at $8,450,512.24. This trade represents a 3.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.February 21, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) COO Sells $87,873.80 in StockFebruary 21, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Short Interest UpdateDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 2,170,000 shares, a growth of 6.4% from the January 15th total of 2,040,000 shares. Approximately 12.1% of the shares of the company are short sold. Based on an average daily volume of 336,500 shares, the short-interest ratio is presently 6.4 days.February 18, 2025 | marketbeat.comBleakley Financial Group LLC Acquires Shares of 7,667 Disc Medicine, Inc. (NASDAQ:IRON)Bleakley Financial Group LLC acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,667 shares of the company's stock, valued at approximatelFebruary 11, 2025 | marketbeat.comStifel Nicolaus Reaffirms Their Buy Rating on Disc Medicine (IRON)February 10, 2025 | markets.businessinsider.comLeerink Partnrs Expects Increased Earnings for Disc MedicineDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Leerink Partnrs boosted their FY2025 earnings per share (EPS) estimates for Disc Medicine in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings perFebruary 10, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells 7,500 Shares of StockFebruary 5, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Insider Rahul Khara Sells 7,500 SharesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider Rahul Khara sold 7,500 shares of Disc Medicine stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $55.54, for a total transaction of $416,550.00. Following the sale, the insider now owns 14,035 shares of the company's stock, valued at approximately $779,503.90. The trade was a 34.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.February 4, 2025 | marketbeat.com Remove Ads Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼0.670.79▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼145▲IRON Articles Average Week Remove Ads Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sarepta Therapeutics News Revolution Medicines News BridgeBio Pharma News Lantheus News TG Therapeutics News Legend Biotech News Axsome Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News Blueprint Medicines News Krystal Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRON Stock Free IRON Stock Alerts